CEO, Ocimum BioSolutions
With strong understanding of
the market needs and requirements, Ocimum
Biosolutions went on an acquisition spree to establish its base in the
Ocimum Biosolutions, a leading
integrated global genomics company providing GLP-compliant microarray
services, comprehensive genomic reference databases, life science lab
information management solutions and essential research consumables,
began its operation first in the US in 2000 and a year later, set up
office in India.
Besides these two markets, during its journey in the last 10 years, the
company has established direct presence in other markets such as
Germany, The Netherlands, the UK and Japan and has presence in many
other countries through partners.
Ocimum Biosolutions, a life sciences R&D enabling company, with the
main focus on three areas: bio-IT, micro-arrays and contract research
services, had signed a letter of intent in 2005 to acquire MWG Biotech
AG’s microarray business, which is the international provider of DNA
sequencing and DNA/siRNA synthesis services for academic and industrial
research with production sites in Germany, the US, and India.
The acquisition was consistent with their strategy to become an
integrated genomics company providing wet lab research tools, bioIT
solutions and contract research services to the pharma and biotech
In order to become a global company, Ocimum later acquired biomolecules
synthesis business of Isogen Life Science based in The Netherlands in
2006. This deal was a significant step towards becoming a global oligo
player. This acquisition helped Ocimum become a more integrated
genomics services provider with three delivery points in Indianapolis,
IJsselstein and Hyderabad.
Continuing its acquisition spree, Ocimum Biosolutions announced the
acquisition of US-based Gene Logic’s genomic business for $10 million
44.7 crore) in 2007. With this acquisition, the company has done
three global acquisitions in the span of three years, a deal per year.
The purchase agreement includes the Maryland-headquartered, Gene
Logic’s knowledge products business, which is anchored by the world’s
largest databases of human biology. As part of the transaction, Ocimum
also acquired Gene Logic’s comprehensive genomic and genetic services
business that provides customers with access to a bio-repository of
over 80,000 samples. Recalling the acquisition, Ms Anuradha Acharya
CEO, Ocimum Biosolutions says, “The genomics business, when integrated
with Ocimum’s strengths in bioIT, biomolecules and bioresearch groups,
forms a premiere business that can support multiple aspects of the life
sciences industry. Gene Logic’s genomics customers will also benefit
from Ocimum’s global presence.”
Currently, with a five-acre campus that has four large units of around
100,000 sq ft in each unit adding to around 400,000 sq ft of lab and
office space in India; and with a 55000 sq ft state-of-the-art lab in
the Gaithersburg area in Maryland (suburb of Washington DC), which is
known as Gene Logic; Ocimum Biosolutions has already established a
strong foothold in the global market.
“We are a global company since we began our operations in 2000 in the
US and 2001 in India. Since then we have been expanding globally both
through acquisitions and by opening offices and presence through
partners,” adds Ms Acharya.